Foot Disease in Diabetes
- 26 January 1995
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (4) , 269-270
- https://doi.org/10.1056/nejm199501263320414
Abstract
In discussing the care of neuropathic ulcers, Caputo et al. (Sept. 29 issue)1 claim that “topical iodine preparations, astringents, and hydrogen peroxide interfere with the healing of the wound,” and they cite two references to support this statement.2,3 The first reference reported not that these topical agents interfered with wound healing but rather that povidone–iodine and saline were less effective than silver sulfadiazine in reducing bacterial counts in chronic pressure ulcers.2 Many other studies have documented the broad antimicrobial effectiveness of povidone–iodine. A controlled clinical study that we sponsored showed that wounds treated with povidone–iodine cream had 100 percent reepithelialization in a significantly shorter period (12.1 days, P4 Several other controlled clinical studies have shown wound healing to be enhanced, rather than harmed, by treatment with povidone–iodine cream.5This publication has 7 references indexed in Scilit:
- Assessment and Management of Foot Disease in Patients with DiabetesNew England Journal of Medicine, 1994
- Improved Quality of Diabetic Foot Care, 1984 vs 1990Archives of Surgery, 1993
- Identifying Diabetic Patients at High Risk for Lower-Extremity Amputation in a Primary Health Care Setting: A prospective evaluation of simple screening criteriaDiabetes Care, 1992
- Hyperbaric Oxygen in Diabetic Gangrene TreatmentDiabetes Care, 1987
- Topical Antimicrobial ToxicityArchives of Surgery, 1985
- The Dysvascular Foot: A System for Diagnosis and TreatmentFoot & Ankle, 1981
- Comparison of Silver Sulfadiazine, Povidone‐Iodine and Physiologic Saline in the Treatment of Chronic Pressure UlcersJournal of the American Geriatrics Society, 1981